Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/LifeMD, Inc.
Company profile

LifeMD, Inc.

NASDAQ: LFMD · Healthcare · Medical - Pharmaceuticals
PublicHQ New York City, NY · New YorkCIK 0000948320Reports USD
#288 of 1,394 Healthcare companies by revenue32nd-percentile growth
EA Score
73B
FH 76DQ 80GM 50SS 73
v0.1 · 65/100 weight · provisional
↑ return on equity, return on assets · ↓ revenue growth (YoY), balance-sheet leverage
Methodology →
Revenue TTM
$219.4M
Rev growth YoY (TTM)
-6.2%
Net income (FY)
$14.4M
Employees
304
Market cap
$235.5M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$194.1M$194.1M2025
Net income$14.4M$14.4M2025
Operating income-$7.7M-$7.7M2025
Total assets$70.4M$70.4M2025
Liabilities$47.3M$47.3M2025
Equity$23.2M$23.2M2025

Revenue trend

FY2019 – FY2025 · USD
$42.5k
FY19
$83.6k
FY19
$37.3M
FY20
$92.9M
FY21
$119.0M
FY22
$152.5M
FY23
$212.5M
FY24
$194.1M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Product and Services100%
By geography

Not disclosed.

The read

LifeMD, Inc. booked $194.1M in FY2025 revenue, contracting 8.7% year over year — slower than 68% of Healthcare companies we track, at a 7.4% net margin.

Peers · Healthcare
TerrAscend Corp.55CEledon Pharmaceuticals, Inc.39DArtiva Biotherapeutics, Inc.40DAtrium Therapeutics, Inc.——
Neighbors
New York →
JPMorgan Chase & Co.$182.4B72BMorgan Stanley$34.3B60CThe Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86AAmerican Express Company$41.3B78B+Citigroup Inc.$85.2B56C
Key facts
CEOJustin Schreiber
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersNew York City, NY
ExchangeNASDAQ: LFMD
Employees304
IPO date2008-01-29
Latest filings
8-K2026-06-228-K2026-05-0610-Q2026-05-06DEF 14A2026-04-308-K2026-03-1810-K2026-03-108-K2026-03-098-K2026-01-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies